inVentiv Health Launches Phase I Services to the U.S.
New Phase I clinical in Miami offers gateway location to Latin America.
inVentiv Health marked the official opening of its new Phase I clinic in the United States, located at the University of Miami Life Science and Technology Park. Key features of the clinic include, but are not limited to:
- 44-bed clinic to expedite progression to Proof of Concept (PoC)
- existing Phase I - Phase IV bioanalytical labs capabilities
- use of new Mytrus Enroll® eConsent technology
- gateway location to Latin America
Read the full release.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
